The MX Q&A: Hugh Martin, Pacific Biosciences
February marks the 10th anniversary of the first draft of human genome sequencing, a long-sought international breakthrough in DNA science.
For Hugh Martin, chairman and CEO of Pacific Biosciences in Menlo Park, CA, February also marks a major step on the company’s journey toward the commercial launch of its PacBio RS system, a multifaceted biotech device that builds on research conducted at Cornell University and the 2001 accomplishment by the Human Genome Project.
At the 12th annual Advances in Genome Biology and Technology Conference in early February, Martin told the gathering of industry leaders in Marco Island, FL, that Pacific Biosciences had begun final upgrades of its beta site instruments. Read the interview here >>>>>>>>